Glenis Willmott

Alcohol labelling should be about what's best for consumers - not industry
16 May
Alcohol labelling should be about what's best for consumers - not industry
When it comes to labelling, there is no reason to treat alcohol differently from other drinks, argues Glenis Willmott.
Rare disease research likely to lose out from Brexit
21 Feb
Rare disease research likely to lose out from Brexit
EU cooperation has been hugely important in advancing research into rare diseases, but Brexit could put an end to this, warns Glenis Willmott.
AMR is a global problem requiring a global response
07 Dec
AMR is a global problem requiring a global response
Failure to tackle antimicrobial resistance could trigger a global catastrophe, warns Glenis Willmott.
Terminal cancer patients deserve better employment protection
16 May
Terminal cancer patients deserve better employment protection
People with a terminal illness should not have to fight to keep their job, writes Glenis Willmott.